Sarah E. Kohe
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma.
Journal: Neuro-oncology
Published: October 08, 2024
Ex vivo metabolite profiling of paediatric central nervous system tumours reveals prognostic markers.
Journal: Scientific reports
Published: January 30, 2019
Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours.
Journal: Scientific reports
Published: February 14, 2018
Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours.
Journal: Oncotarget
Published: December 05, 2017
Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles.
Journal: Oncotarget
Published: September 08, 2017
Metabolite Levels in Paediatric Brain Tumours Correlate with Histological Features.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: July 01, 2016
Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups.
Journal: British journal of cancer
Published: March 16, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026